This article is cross-posted with permission from Bereskin & Parr. The United States Patent and Trademarks Office (USPTO) has released an updated set of Eligibility Examination Guidelines to provide guidance…
Tag: Myriad Genetics
SickKids in Court - Are Public-Private Research Collaborations a Hindrance or a Driver of the Innovative Process?
A recent lawsuit filed by Myriad Genetics involving the alleged infringement of their controversial breast cancer screening tool has included the prestigious Toronto SickKids hospital as a co-plaintiff. This lawsuit…
The ‘Myriad’ with the Golden ‘Gene’: Australia Upholds Breast Cancer Gene Patents
The Myriad Genetics gene patenting saga has officially shaped international jurisprudence, with the Federal Court of Australia upholding the patents for BRCA1 and BRCA2. In Cancer Voices Australia v. Myriad…
Live and Let Die: Gene Patenting Plot Thickens as the Patent/Trade Secret Line is Blurred
The long battle in the American courts over Myriad Genetics’ patents of BRCA1 and BRCA2, the primary diagnostic genes for hereditary breast and ovarian cancer has been well-documented in the…
Staying Abreast of an Isolating Issue: USSC to Rule on Patentability of Human Genes
On November 30, 2012 the US Supreme Court agreed to hear the appeal in the case of Association for Molecular Pathology v Myriad Genetics Inc. In particular, the Court limited…
The Patentability of Gene Sequences: Myriad Genetics’ Day in the United States Supreme Court
In late March, The United States Supreme Court ordered the U.S Court of Appeal for the Federal Circuit to reconsider Myriad Genetics’ existing patent on two genes associated with a…